Skip to main content
Clinical Trials/NCT01088425
NCT01088425
Completed
Not Applicable

Maternal Pregnancy and Neonatal Outcome After Assisted Reproduction. Comparison of Vitrification vs. Spontaneous Conception

University of Luebeck1 site in 1 country850 target enrollmentMarch 2010
ConditionsPregnancy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pregnancy
Sponsor
University of Luebeck
Enrollment
850
Locations
1
Primary Endpoint
Maternal pregancy outcome
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Great scientific effort has been made to improve practical as well as economical procedures of modern assisted reproduction.

In the last years a shift from the well established method of slow-rate freezing to vitrification of 2PN zygotes and embryos could be observed. Like any other method of cryopreservation, the outcome of vitrification will be affected by several factors related to technique itself, its practical management and patient characteristics.

The investigators want to investigate the influence of vitrification on the outcome of of 2PN oocytes, pregnancy and infant health.

A Comparison between a cohort of spontaneous conceived children and children of vitrified and slow- cooled 2PN oocytes is planned.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
December 2015
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University of Luebeck
Responsible Party
Principal Investigator
Principal Investigator

Daniel Alexander Beyer

Dr. D. A. Beyer

University of Luebeck

Eligibility Criteria

Inclusion Criteria

  • cryopreservation (vitrification and slow- rate freezing) between 1998 - 2010
  • Treatment in Lübeck University
  • Delivery in Lübeck University
  • Positive informed consent

Exclusion Criteria

  • Negative informed consent

Outcomes

Primary Outcomes

Maternal pregancy outcome

Time Frame: 7 years

spontaneous or operative delivery, birth injuries, conjoined morbidity

embryo survival

Time Frame: 7 years

embryo survival rate

Secondary Outcomes

  • infant health(7 years)

Study Sites (1)

Loading locations...

Similar Trials